Related Experiment Videos
RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor
Michele D Vos1, Chad A Ellis, Candice Elam
1Department of Cell and Cancer Biology, NCI, National Institutes of Health, Rockville, Maryland 20850-3300, USA.
The Journal of Biological Chemistry
|May 7, 2003
Summary
Researchers identified RASSF2, a novel Ras effector and tumor suppressor. This protein, RASSF2, specifically interacts with K-Ras and induces apoptosis and cell cycle arrest, suggesting its role in lung cancer.
Area of Science:
- Molecular biology
- Cell biology
- Oncology
Background:
- Ras proteins are key regulators of cellular processes, with aberrant forms linked to oncogenesis.
- Ras effector proteins mediate diverse cellular outcomes, including growth inhibition and apoptosis.
- The tumor suppressor roles of Ras effectors like NORE1 and RASSF1 are established, but novel family members remain to be fully characterized.
Purpose of the Study:
- To identify and characterize a novel Ras effector protein.
- To investigate the interaction specificity and functional consequences of this new effector.
- To determine the potential role of this effector in cancer, specifically lung tumors.
Main Methods:
- GTP-binding assays to assess Ras protein interactions.
- Apoptosis assays to evaluate cell death induction.
- Cell cycle analysis to determine cell cycle arrest.
- Expression analysis in lung tumor cell lines.
Main Results:
- A novel Ras effector, RASSF2, was identified.
- RASSF2 binds GTP-dependent K-Ras but not H-Ras.
- RASSF2 induces apoptosis and cell cycle arrest.
- RASSF2 is frequently downregulated in lung tumor cell lines.
Conclusions:
- RASSF2 is a new member of the RASSF1 family of Ras effectors and tumor suppressors.
- RASSF2 exhibits specificity for K-Ras, mediating growth-inhibitory signals.
- Downregulation of RASSF2 in lung tumors suggests its role as a tumor suppressor.